Status:
UNKNOWN
Assessment of Macular Edema Using HRT Technique
Lead Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Conditions:
Age-Related Macular Degeneration
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Age Related Macular Degeneration (ARMD) is the most common cause of irreversible blindness in people of age 50 or older in the western populations. ARMD has two forms, the wet and the dry forms. The w...
Detailed Description
Introduction: Age-related macular degeneration (ARMD) is a spectrum of related diseases that affects the macula and it has been traditionally classified into early and late stages with its dry (non-ex...
Eligibility Criteria
Inclusion
- New patients referred by general ophthalmologists to the retina specialist for possible diagnosis of ARMD, exudative formed, will be included in the study.
Exclusion
- Significant media opacity
- Other causes of macular edema (ME) (diabetes, vascular occlusions)
- Diabetic patients with retinopathy
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2009
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00627718
Start Date
April 1 2008
End Date
July 1 2009
Last Update
March 3 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MUHC
Montreal, Quebec, Canada, H3A 1A1